The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 1 August 2005. doi:10.1084/jem.20041961
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 202, Number 3, 425-435
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoneyama, H.
Right arrow Articles by Matsushima, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoneyama, H.
Right arrow Articles by Matsushima, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs

Hiroyuki Yoneyama1, Kenjiro Matsuno2, Etsuko Toda1, Tetsu Nishiwaki1, Naoki Matsuo1, Akiko Nakano1, Shosaku Narumi1, Bao Lu3, Craig Gerard3, Sho Ishikawa1, and Kouji Matsushima1

1 Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
2 Department of Anatomy (Macro) and SORST, Dokkyo University School of Medicine, Tochigi 321-0293, Japan
3 Department of Pediatrics, Children's Hospital, Harvard Medical School, Boston, MA 02115

CORRESPONDENCE Kouji Matsushima: koujim{at}m.u-tokyo.ac.jp

Antiviral cell–mediated immunity is initiated by the dendritic cell (DC) network in lymph nodes (LNs). Plasmacytoid DCs (pDCs) are known to migrate to inflamed LNs and produce interferon (IFN)-{alpha}, but their other roles in antiviral T cell immunity are unclear. We report that LN-recruited pDCs are activated to create local immune fields that generate antiviral cytotoxic T lymphocytes (CTLs) in association with LNDCs, in a model of cutaneous herpes simplex virus (HSV) infection. Although pDCs alone failed to induce CTLs, in vivo depletion of pDCs impaired CTL-mediated virus eradication. LNDCs from pDC-depleted mice showed impaired cluster formation with T cells and antigen presentation to prime CTLs. Transferring circulating pDC precursors from wild-type, but not CXCR3-deficient, mice to pDC-depleted mice restored CTL induction by impaired LNDCs. In vitro co-culture experiments revealed that pDCs provided help signals that recovered impaired LNDCs in a CD2- and CD40L-dependent manner. pDC-derived IFN-{alpha} further stimulated the recovered LNDCs to induce CTLs. Therefore, the help provided by pDCs for LNDCs in primary immune responses seems to be pivotal to optimally inducing anti-HSV CTLs.


Abbreviations used: Ab, antibody; BrdU, 5'-bromo- 2'-deoxyuridine; CFSE, carboxyfluorescein diacetate succinimidyl ester; HEV, high endothelial venule; mDC, myeloid DC; pDC, plasmacytoid DC; PDCA, pDC antigen; PLN, popliteal LN; rpm, revolutions per minute.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS